« Previous
Next »
Journal of the Formosan Medical Association
Volume 106, Issue 11
, Pages 919-928
, November 2007
Circulating Levels of Markers of Inflammation and Endothelial Activation are Increased in Men with Chronic Spinal Cord Injury
References
- Cardiovascular alterations after spinal cord injury: an overview . Curr Med Chem Cardiovasc Hematol Agents . 2004;2:133–148
- Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago . Paraplegia . 1992;30:617–630
- Tomographic thallium-201 myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quad-riplegia . Arch Phys Med Rehabil . 1993;74:740–744
- Cardiac stress testing with thallium-201 imaging reveals silent ischemia in individuals with paraplegia . Arch Phys Med Rehabil . 1994;75:946–950
- . Inflammatory bio-markers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation . Circulation . 2006;113:e152–e155
- . Inflammation in atherosclerosis . Nature . 2002;420:868–874
- New markers of inflammation and endothelial cell activation: Part I . Circulation . 2003;108:1917–1923
- . Fitness, inflammation, and the metabolic syndrome in men with paraplegia . Arch Phys Med Rehabil . 2005;86:1176–1181
- Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury . Arch Phys Med Rehabil . 2005;86:312–317
- Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries . Arch Phys Med Rehabil . 1997;78:44–47
- Serial concentrations of C-reactive protein as an indicator of urinary tract infection in patients with spinal injury . J Clin Pathol . 1986;39:851–855
- CDC/AHA workshop on markers of inflammation and cardiovascular disease . Circulation . 2004;110:e545–e549
- International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association . Spinal Cord . 1997;35:266–274
- Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population . Am J Cardiol . 2001;88:737–743
- Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylargi-nine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome . Am J Cardiol . 2006;98:1057–1062
- . Decline in muscle mass with age in women: a longitudinal study using an indirect measure . Metabolism . 2002;51:935–939
- Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group . Lancet . 1997;349:462–466
- Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men . N Engl J Med . 1997;336:973–979
- Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease . Am J Cardiol . 2005;95:236–240
- Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study . Circulation . 2004;110:386–391
-
Chronic sub-clinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)
.
Circulation
. 2000;102:42–47
- Factors influencing body composition in persons with spinal cord injury: a cross-sectional study . J Appl Physiol . 2003;95:2398–2407
- High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome . Metabolism . 2006;55:1014–1021
- Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris . Am J Cardiol . 2006;97:1702–1706
- Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury . Arch Phys Med Rehabil . 2000;81:506–516
- . Endothelin: beyond a vasoconstrictor . Circulation . 2006;113:1156–1158
- A novel potent vasoconstrictor peptide produced by endothelial cells . Nature . 1988;332:411–415
- Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome . Metabolism . 2000;49:748–752
- Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans . Eur J Endocrinol . 2004;150:195–200
- Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis . Int J Cardiol . 2004;96:235–240
- . Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population . Int J Obes . 2006;30:1176–1182
- ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats . Hypertension . 2004;43:872–879
- . Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions . J Am Coll Cardiol . 2005;46:1978–1985
PII: S0929-6646(08)60062-5
doi: 10.1016/S0929-6646(08)60062-5
© 2007 Formosan Medical Association & Elsevier. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of the Formosan Medical Association
Volume 106, Issue 11
, Pages 919-928
, November 2007
